Watch Live


EMA Says Possible Shortage of Genzyme’s Thyrogen Medicine

The European Medicines Agency said it was informed by Genzyme Corp. (GENZ) of a possible supply shortage of Thyrogen due to a manufacturing issue, according to an e- mailed statement from the agency.

To contact the editor responsible for this story: Kristen Hallam at

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.